- Home
- ISRL vs SENS Comparison
ISRL vs SENS Comparison
Compare ISRL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRL
- SENS
- Stock Information
- Founded
- ISRL 2021
- SENS 1996
- Country
- ISRL United States
- SENS United States
- Employees
- ISRL N/A
- SENS N/A
- Industry
- ISRL Blank Checks
- SENS Industrial Machinery/Components
- Sector
- ISRL Finance
- SENS Industrials
- Exchange
- ISRL Nasdaq
- SENS Nasdaq
- Market Cap
- ISRL 79.7M
- SENS 357.2M
- IPO Year
- ISRL 2023
- SENS N/A
- Fundamental
- Price
- ISRL $12.63
- SENS $0.45
- Analyst Decision
- ISRL
- SENS Strong Buy
- Analyst Count
- ISRL 0
- SENS 5
- Target Price
- ISRL N/A
- SENS $1.63
- AVG Volume (30 Days)
- ISRL 2.1K
- SENS 5.0M
- Earning Date
- ISRL 01-01-0001
- SENS 11-06-2025
- Dividend Yield
- ISRL N/A
- SENS N/A
- EPS Growth
- ISRL N/A
- SENS N/A
- EPS
- ISRL 0.14
- SENS N/A
- Revenue
- ISRL N/A
- SENS $25,466,000.00
- Revenue This Year
- ISRL N/A
- SENS $63.52
- Revenue Next Year
- ISRL N/A
- SENS $67.91
- P/E Ratio
- ISRL $93.55
- SENS N/A
- Revenue Growth
- ISRL N/A
- SENS 5.94
- 52 Week Low
- ISRL $11.14
- SENS $0.25
- 52 Week High
- ISRL $14.00
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- ISRL 52.16
- SENS 43.64
- Support Level
- ISRL $11.99
- SENS $0.44
- Resistance Level
- ISRL $12.70
- SENS $0.47
- Average True Range (ATR)
- ISRL 0.11
- SENS 0.02
- MACD
- ISRL 0.01
- SENS 0.00
- Stochastic Oscillator
- ISRL 90.14
- SENS 18.80
About ISRL Israel Acquisitions Corp
Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.